Related Experiment Video

Updated: May 20, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Sclerostin monoclonal antibodies on bone metabolism and fracture healing

Zakareya Gamie1, Nectarios Korres, Andreas Leonidou

  • 1Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Department of Trauma and Orthopaedic Surgery, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK.

Expert Opinion on Investigational Drugs
|August 2, 2012
PubMed
Abstract

Insights

Sclerostin inhibition enhances bone formation and fracture healing. Studies show sclerostin antibodies promote bone healing and density in vivo and in early clinical trials, suggesting potential for treating fractures.

Area of Science:

  • Orthopedics
  • Bone Biology
  • Pharmacology

Background:

  • Fracture healing complications like non-union can be prevented by biological enhancement.
  • Sclerostin, produced by osteocytes, inhibits Wnt signaling and reduces bone formation by binding LRP5/6 receptors.

Purpose of the Study:

  • To review current literature on sclerostin's role in bone formation and fracture healing.
  • To present an update on the use of sclerostin inhibitors for promoting bone healing.

Main Methods:

  • Review of in vivo studies investigating sclerostin gene deletion and sclerostin antibodies.
  • Analysis of early clinical studies on sclerostin antibodies for bone mineral density and safety.

Main Results:

  • Sclerostin gene deletion enhances bone formation and fracture healing in rodent models.
  • Sclerostin antibodies show promise in vivo for fracture healing, screw fixation, and metaphyseal bone healing.
  • Early clinical studies indicate sclerostin antibodies increase bone mineral density safely and are well-tolerated.

Conclusions:

  • Sclerostin inhibition is a promising strategy for enhancing fracture healing.
  • Further investigation of sclerostin inhibitors is supported by current data for fracture treatment.
  • Sclerostin antibodies represent a potential therapeutic agent for promoting bone formation and healing.

More Related Videos

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...